The June 2016 Transplant Trial Watch is now available. This month, the trial watch includes systematic reviews of quality of life reporting in renal transplant trials and extended criteria donors, as well as an analysis of wound complications with everolimus following cardiac transplantation.
The March edition of the Transplant Trial Watch is now available via our website and the Trial Watch App. This month’s trials include the effect of Omega-3 on hepatic regeneration after live liver donation, prophylactic azithromycin after lung transplantation, and the consequences of complete tacrolimus withdrawal in renal transplant recipients.
On the 3rd February 2016, a group of 20 kidney transplant recipients, donors and professionals took part in a consensus workshop at the Royal College of Surgeons of England, in London. The group considered the top 25 ranked treatment uncertainties from the PSP prioritisation survey, and after much lively debate agreed a top ten list […]
The CET team would like to wish everyone a Happy New Year! A new year means that this month’s Transplant Trial Watch is now out. New studies include a systematic review of outcomes in obese kidney transplant recipients, CNI and steroid-free immunosuppression in renal transplantation, and a direct mail campaign to improve donor registration.
Do you want to increase your skills in evidence-based decision-making? Attend the “Evidence in Transplantation (EVIT) course”, which is held at the Royal College of Surgeons of England on 8-9 April, 2016 and jointly organised by ESOT and the Centre for Evidence in Transplantation. This interactive course covers clinical research methods, including clinical trial design and […]
The December 2015 edition of the Transplant Trial Watch is now available online. This month’s trials include the first RCT of robotic donor nephrectomy, Belatacept in Liver Transplantation and tPA for DCD kidney donors. Why not download our app for iPhone, iPad and Android?
The October 2015 edition of the Transplant Trial watch is now available online and via the Trial Watch app. This month, new studies include long-term outcomes of sirolimus-based immunosuppression in renal transplant recipients, remote ischaemic preconditioning and therapeutic hypothermia in organ donors.
The Texas Transplantation Society is the first US society to provide access to the Transplant Library database for all its members. The Transplant Library will be introduced by Sir Peter Morris by video and by Mr Mark Schregardus, CEO of Evidentia Publishing during 28th Annual Scientific Meeting of the Texas Transplantation Society, July 23-26, 2015, […]